Q1 2025 Shaily Engineering Plastics Ltd Earnings Call Transcript
Key Points
- Shaily Engineering Plastics Ltd (BOM:501423) reported a robust top line growth of 14% to INR 179 crores in Q1 FY '25.
- Gross margins and EBITDA margins improved to 42.1% and 20.1%, respectively.
- The company received purchase orders for one of its pen injectors amounting to 10 million units per year.
- Shaily U.K. has shown significant growth and is building capabilities to cater to big pharma.
- The company has entered into new contracts to develop two new pen injectors in the Healthcare segment.
- Machine utilization rate was around 39% in Q1 FY '25, indicating underutilization of capacity.
- Domestic revenue showed a bit of degrowth, with quarterly figures not meeting expectations.
- The company faces challenges in the European market, with no significant demand recovery observed.
- There were technical engineering challenges in Q1 that affected supply timelines.
- The insulin business, although stable, is price-sensitive and significantly commoditized, impacting margins.
Ladies and gentlemen, good day, and welcome to Shaily Engineering Plastics Limited Q1 FY '25 Earnings Conference Call. This conference call may contain forward-looking statements about the company, which are based on the beliefs, opinions and expectations of the company as on date of this call. These statements are not the guarantees of future performance and involve risks and uncertainties that are difficult to predict. (Operator Instructions)
Please note that this conference is being recorded. I now hand the conference over to the Managing Director of Shaily Engineering Plastics Limited, Mr. Amit Sanghvi. Thank you, and over to you, sir.
Thank you very much. Good evening, and a very warm welcome to all the participants to the post results investor call of Shaily Engineering Plastics. I have with me Mr. Sanjay Shah, our Chief Strategy Officer; and SGA, our Investor Relations advisers. I hope you've had a look at our investor presentation that is uploaded on our website and the stock
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
